Yahoo Web Search

Search results

1. • 

     BMS secures another EC approval for Opdivo combination

     Pharmaceutical Technology via Yahoo Finance· 7 days ago

     Previously, there were no marketed therapies that improved overall survival in patients with...

2. • 

     Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)

     Zacks via Yahoo Finance· 3 hours ago

     Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...

3. • 

     EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer

     Pharmaceutical Technology via Yahoo Finance· 1 day ago

     This study assessed Tagrisso in combination with pemetrexed and platinum-based chemotherapy in 557...

4. • 

     Secondhand Smoke Increases Cisplatin Resistance in HNC

     Medscape· 6 days ago

     Dr Maurie Markman discusses results from a study suggesting that secondhand smoke exposure may...

5. • 

     ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours

     Clinical Trials Arena via Yahoo Finance· 2 days ago

     The therapy was evaluated as a monotherapy and in combination with AbbVie’s investigative programmed...

6. • 

     EMA Panel Nods to Seven New Cancer Drugs

     Medscape· 5 days ago

     The drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.

7. • Engineered DNA 'warhead' targets a common cancer mutation

     Medical Xpress· 6 days ago

     Tumor protein P53 (TP53) plays an important role in suppressing the growth of tumors. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumors ...